PARA_OA_008 top-line data readout September 2022
• Canine OA model preliminary data readout Q3 CY2022
• PARA_OA_002 Update – First data safety monitoring board review Q4 CY2022
• PARA_OA_006 extension study commencement Q4 CY2022
• FY22 tax rebate Q4 CY2022
• Further IP generation and protection
• MPS-I data presented at International Conference on Lysosomal Diseases Q1 CY2023
• PARA_OA_008 6-month data Q1 CY2023
• Canine OA Model – 20-week follow-up (3-year human equivalent) data
Q1 CY2023
• PARA_OA_002 Stage 1 dose selection 1H CY2023.
• Paradigm is currently in active discussion with multiple potential partners for its Phase 2 asset in Mucopolysaccharidosis (MPS).
Ann: Paradigm Launches $66M Capital Raising, page-13
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $94.44M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.0¢ | 27.0¢ | $127.7K | 460.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 287444 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 100870 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
27.0¢ |
Change
-0.010 ( 5.69 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 29.0¢ | 27.0¢ | 132157 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| PAR (ASX) Chart |